Lu et al., 2003 - Google Patents
A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agentLu et al., 2003
- Document ID
- 14896453596017116920
- Author
- Lu E
- Jiang Z
- Zhang Q
- Jiang X
- Publication year
- Publication venue
- Journal of controlled release
External Links
Snippet
A monolithic osmotic tablet system (MOTS) with two orifices in both side surfaces has been studied. Water-insoluble naproxen was selected as the model drug. Gum arabic was used as an osmotic, suspending and expanding agent, and cellulose acetate (CA) was used as …
- 239000003814 drug 0 title abstract description 69
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lu et al. | A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent | |
| Thombre et al. | Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients | |
| Makhija et al. | Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine: I. Cellulose acetate as a semipermeable membrane | |
| JP3745382B2 (en) | Solid formulations containing a physical mixture of a sulfoalkyl ether cyclodextrin and a therapeutic agent | |
| Prabakaran et al. | Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps | |
| Remuñán-López et al. | Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery | |
| Liu et al. | Nifedipine controlled delivery by sandwiched osmotic tablet system | |
| Liu et al. | Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation | |
| Krishnaiah et al. | In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil | |
| Lin et al. | Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice | |
| US5681584A (en) | Controlled release drug delivery device | |
| Thombre et al. | Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance | |
| Özdemir et al. | Design of a controlled release osmotic pump system of ibuprofen | |
| Mundargi et al. | Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis | |
| Prabakaran et al. | Modified push–pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization | |
| JP2005536568A (en) | Formulations and dosage forms for the controlled distribution of topiramate | |
| JP2002528486A5 (en) | ||
| NL8502930A (en) | THERAPEUTIC DELIVERY SYSTEM FOR THE COLON. | |
| MXPA03001209A (en) | Hydrogel-driven drug dosage form. | |
| Jerzewski et al. | Osmotic drug delivery | |
| JP2006316076A (en) | Sulfoalkyl ether cyclodextrin-based controlled release solid pharmaceutical formulations | |
| FR2842736B1 (en) | ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A PLURALITY OF MICROCAPSULES FOR PROLONGED RELEASE OF LOW SOLUBLE ACTIVE (S) PRINCIPLE (S) | |
| Wang et al. | Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects | |
| Kranz et al. | Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations | |
| Philip et al. | Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil |